Our first Q & A Session will take place on September 4th, 2024 from 4-5pm EST
Our first guest will be Dr. John Kuruvilla
Get your Questions Answered by a leading Lymphoma/CLL Specialist!
We are thrilled to announce the launch of our new Q&A program, “Ask a Lymphoma/CLL Specialist,” a unique opportunity to get your questions answered by leading experts in the field of lymphoma and chronic lymphocytic leukemia (CLL). This inaugural session features Dr. John Kuruvilla, a renowned specialist with extensive experience in treating lymphoma. Dr. Kuruvilla will provide detailed, personalized responses to your most pressing questions, helping you navigate your journey with lymphoma or CLL with greater understanding and confidence.
We invite you to submit your questions in the forum below. Whether you’re curious about symptoms, treatment options, side effects, or daily management, no question is too big or too small. By participating, you not only get the chance to have your questions addressed but also contribute to a richer, more informed community discussion.
Don’t forget to register to attend the webinar live to hear Dr. Kuruvilla’s answers to your questions. This is an excellent opportunity to gain insights directly from a top expert and learn from the experiences of others in the community. Join us for this insightful session and empower yourself with knowledge from one of the best in the field.
*Please contact info@lymphoma.ca if you encounter any issues submitting your questions or registering for the Live Q&A.*
Meet our Specialist: Dr. John Kuruvilla
Dr. John Kuruvilla is a Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co- Director of the Beyond Chemotherapy Program. Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Learn more and find additional useful resources through the links below:
Lymphoma Canada’s “Ask a Lymphoma/CLL Specialist” Q&A program is made possible by our generous sponsors:
